JoAnn E. Manson, MD, DrPH; Chrisandra L. Shufelt, MD; James M. Robins, MD
In this Viewpoint, JoAnn Manson and colleagues discuss the risk of postrandomization 鈥渃onfounding,鈥 a bias that can be introduced in long-duration trials of sustained interventions, using statin initiation after randomization in Women鈥檚 Health Initiative trials as an example.